|
US7291615B2
(en)
|
2003-05-01 |
2007-11-06 |
Bristol-Myers Squibb Company |
Cyclic derivatives as modulators of chemokine receptor activity
|
|
CA2553871A1
(en)
*
|
2004-01-16 |
2005-08-04 |
The Regents Of The University Of Michigan |
Smac peptidomimetics and the uses thereof
|
|
EP1713542A2
(en)
*
|
2004-02-05 |
2006-10-25 |
Novartis AG |
COMBINATION OF (a) A DNA TOPOISOMERASE INHIBITOR AND (b) AN IAP INHIBITOR
|
|
CA2558615C
(en)
|
2004-03-23 |
2013-10-29 |
Genentech, Inc. |
Azabicyclo-octane inhibitors of iap
|
|
RS52545B
(sr)
*
|
2004-04-07 |
2013-04-30 |
Novartis Ag |
Inhibitori protein apoptoze (iap)
|
|
CA2570321C
(en)
*
|
2004-07-02 |
2013-10-08 |
Genentech, Inc. |
Inhibitors of iap
|
|
WO2006020060A2
(en)
|
2004-07-15 |
2006-02-23 |
Tetralogic Pharmaceuticals Corporation |
Iap binding compounds
|
|
KR20120127754A
(ko)
|
2004-12-20 |
2012-11-23 |
제넨테크, 인크. |
Iap의 피롤리딘 억제제
|
|
DK1851200T3
(da)
|
2005-02-25 |
2014-04-14 |
Tetralogic Pharm Corp |
Dimere iap-inhibitorer
|
|
DE102005017116A1
(de)
*
|
2005-04-13 |
2006-10-26 |
Novartis Ag |
Hemmstoffe für Inhibitoren von Apoptose Proteinen (IAP)
|
|
JP4954983B2
(ja)
|
2005-05-18 |
2012-06-20 |
ファーマサイエンス・インコーポレイテッド |
Birドメイン結合化合物
|
|
US8318717B2
(en)
|
2005-05-25 |
2012-11-27 |
2Curex |
Compounds modifying apoptosis
|
|
WO2006128455A2
(en)
|
2005-05-25 |
2006-12-07 |
2Curex Aps |
Compounds modifying apoptosis
|
|
US20100256046A1
(en)
*
|
2009-04-03 |
2010-10-07 |
Tetralogic Pharmaceuticals Corporation |
Treatment of proliferative disorders
|
|
RU2418807C2
(ru)
|
2005-10-25 |
2011-05-20 |
Аегера Терапьютикс Инк. |
Соединения, связывающие bir домены iap
|
|
RU2451025C2
(ru)
|
2005-12-19 |
2012-05-20 |
Дженентек, Инк. |
Ингибиторы iap
|
|
EP2606933A3
(en)
|
2005-12-20 |
2014-10-15 |
Novartis AG |
Combination of an IAP-inhibitor and a taxane
|
|
DK1966130T3
(da)
*
|
2005-12-23 |
2014-02-10 |
Zealand Pharma As |
Modificerede lysin-mimetiske forbindelser
|
|
TWI543988B
(zh)
*
|
2006-03-16 |
2016-08-01 |
科學製藥股份有限公司 |
結合於細胞凋亡抑制蛋白(iap)之桿狀病毒iap重複序列(bir)區域之化合物
|
|
SG10201407457UA
(en)
*
|
2006-05-16 |
2014-12-30 |
Pharmascience Inc |
Iap bir domain binding compounds
|
|
JP5452223B2
(ja)
|
2006-07-24 |
2014-03-26 |
テトラロジック ファーマシューティカルズ コーポレーション |
Iap阻害剤
|
|
CL2007002167A1
(es)
|
2006-07-24 |
2009-01-23 |
Tetralogic Pharm Corp |
Compuestos derivados de indol, antagonistas iap; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de cancer.
|
|
WO2008014229A2
(en)
*
|
2006-07-24 |
2008-01-31 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
US20100056495A1
(en)
*
|
2006-07-24 |
2010-03-04 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
WO2008014238A2
(en)
*
|
2006-07-24 |
2008-01-31 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
WO2008014240A2
(en)
*
|
2006-07-24 |
2008-01-31 |
Tetralogic Pharmaceuticals Corporation |
Dimeric iap inhibitors
|
|
PE20110218A1
(es)
|
2006-08-02 |
2011-04-01 |
Novartis Ag |
DERIVADOS DE 2-OXO-ETIL-AMINO-PROPIONAMIDA-PIRROLIDIN-2-IL-SUSTITUIDOS COMO INHIBIDORES DEL ENLACE DE LA PROTEINA Smac AL INHIBIDOR DE LA PROTEINA DE APOPTOSIS
|
|
US8044209B2
(en)
|
2006-10-12 |
2011-10-25 |
Novartis Ag |
Pyrrolydine derivatives as IAP inhibitors
|
|
CA2670498A1
(en)
|
2006-11-28 |
2008-06-05 |
Novartis Ag |
Combination of iap inhibitors and flt3 inhibitors
|
|
RU2466131C2
(ru)
*
|
2006-12-19 |
2012-11-10 |
Дженентек, Инк. |
Имидазопиридиновые ингибиторы iap
|
|
WO2008079266A2
(en)
|
2006-12-21 |
2008-07-03 |
Wyeth |
Synthesis of pyrrolidine compounds
|
|
WO2008128121A1
(en)
*
|
2007-04-12 |
2008-10-23 |
Joyant Pharmaceuticals, Inc. |
Smac mimetic dimers and trimers useful as anti-cancer agents
|
|
NZ598890A
(en)
|
2007-04-30 |
2013-10-25 |
Genentech Inc |
Inhibitors of iap
|
|
CA2686638A1
(en)
*
|
2007-05-07 |
2008-11-13 |
Tetralogic Pharmaceuticals Corp. |
Tnf.alpha. gene expression as a biomarker of sensitivity to antagonists of inhibitor of apoptosis proteins
|
|
PL2240506T3
(pl)
*
|
2008-01-11 |
2013-05-31 |
Genentech Inc |
Inhibitory IAP
|
|
CA2730448A1
(en)
|
2008-08-02 |
2010-02-11 |
Genentech, Inc. |
Inhibitors of iap
|
|
JP2012500272A
(ja)
*
|
2008-08-16 |
2012-01-05 |
ジェネンテック, インコーポレイテッド |
Iapのアザインドールインヒビター
|
|
US8283372B2
(en)
*
|
2009-07-02 |
2012-10-09 |
Tetralogic Pharmaceuticals Corp. |
2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
|
|
AR077688A1
(es)
|
2009-08-04 |
2011-09-14 |
Takeda Pharmaceutical |
Compuestos heterociclicos, utiles en el tratamiento de cancer
|
|
BR112012003118A2
(pt)
|
2009-08-12 |
2016-02-23 |
Novartis Ag |
formulações orais sólidas e formas cristalinas de um inibidor de proteína apoptose
|
|
WO2011035083A1
(en)
*
|
2009-09-18 |
2011-03-24 |
Novartis Ag |
Biomarkers for iap inhibitor compounds
|
|
CN102050867A
(zh)
*
|
2009-11-10 |
2011-05-11 |
上海艾力斯医药科技有限公司 |
四肽类似物、制备方法及其应用
|
|
MX340870B
(es)
|
2010-02-12 |
2016-07-27 |
Pharmascience Inc |
Compuestos de unión del dominio de repetición de inhibidores de proteínas de apoptosis de baculovirus.
|
|
JP2015508414A
(ja)
|
2012-01-12 |
2015-03-19 |
イエール ユニバーシティ |
E3ユビキチンリガーゼによる標的タンパク質および他のポリペプチドの分解増強のための化合物および方法
|
|
US8859541B2
(en)
*
|
2012-02-27 |
2014-10-14 |
Boehringer Ingelheim International Gmbh |
6-alkynylpyridines
|
|
GB201311888D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel compounds
|
|
GB201311891D0
(en)
|
2013-07-03 |
2013-08-14 |
Glaxosmithkline Ip Dev Ltd |
Novel compound
|
|
US10441654B2
(en)
|
2014-01-24 |
2019-10-15 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
SMC combination therapy for the treatment of cancer
|
|
US20180228907A1
(en)
|
2014-04-14 |
2018-08-16 |
Arvinas, Inc. |
Cereblon ligands and bifunctional compounds comprising the same
|
|
US10071164B2
(en)
|
2014-08-11 |
2018-09-11 |
Yale University |
Estrogen-related receptor alpha based protac compounds and associated methods of use
|
|
US12312316B2
(en)
|
2015-01-20 |
2025-05-27 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of androgen receptor
|
|
HK1245791A1
(zh)
|
2015-01-20 |
2018-08-31 |
阿尔维纳斯运营股份有限公司 |
用於雄激素受体的靶向降解的化合物和方法
|
|
GB201506872D0
(en)
|
2015-04-22 |
2015-06-03 |
Ge Oil & Gas Uk Ltd |
Novel compounds
|
|
WO2016197114A1
(en)
|
2015-06-05 |
2016-12-08 |
Arvinas, Inc. |
Tank-binding kinase-1 protacs and associated methods of use
|
|
CA2988436A1
(en)
*
|
2015-07-13 |
2017-01-19 |
Arvinas, Inc. |
Alanine-based modulators of proteolysis and associated methods of use
|
|
EP3337476A4
(en)
|
2015-08-19 |
2019-09-04 |
Arvinas, Inc. |
Compounds and methods for the targeted degradation of bromodomain-containing proteins
|
|
AU2016349781A1
(en)
|
2015-11-02 |
2018-05-10 |
Yale University |
Proteolysis targeting chimera compounds and methods of preparing and using same
|
|
EP3535265A4
(en)
|
2016-11-01 |
2020-07-08 |
Arvinas, Inc. |
PROTACS TARGETING ON TAU PROTEIN AND RELATED METHODS FOR USE
|
|
WO2018102725A1
(en)
|
2016-12-01 |
2018-06-07 |
Arvinas, Inc. |
Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders
|
|
EP3559006A4
(en)
|
2016-12-23 |
2021-03-03 |
Arvinas Operations, Inc. |
COMPOUNDS AND METHODS FOR TARGETED DEGRADATION OF F TAL LIVER KINASE POLYPEPTIDES
|
|
US11173211B2
(en)
|
2016-12-23 |
2021-11-16 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of rapidly accelerated Fibrosarcoma polypeptides
|
|
EP3558994A4
(en)
|
2016-12-23 |
2021-05-12 |
Arvinas Operations, Inc. |
COMPOUNDS AND METHODS FOR TARGETED DEGRADATION OF FAST ACCELERATED FIBROSARCOMA POLYPEPTIDES
|
|
RU2019121527A
(ru)
|
2016-12-23 |
2021-01-15 |
Эрвинэс Оперейшнс, Инк. |
Химерные молекулы, нацеливающиеся на протеолиз egfr, и связанные с ними способы применения
|
|
US11191741B2
(en)
|
2016-12-24 |
2021-12-07 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide
|
|
MX2019008934A
(es)
|
2017-01-26 |
2019-11-05 |
Arvinas Operations Inc |
Moduladores de la proteolisis del receptor de estrogeno y métodos asociados de uso,.
|
|
JP6989864B2
(ja)
|
2017-05-05 |
2022-02-03 |
ジーランド ファーマ,アー/エス |
ギャップ結合細胞間コミュニケーションモジュレータ及び糖尿病性眼疾患の治療のためのそれらの使用
|
|
WO2019023275A1
(en)
*
|
2017-07-25 |
2019-01-31 |
Hepagene Therapeutics, Inc. |
PEPTIDE INHIBITORS DIMERS OF APOPTOSIS PROTEINS
|
|
WO2019021289A1
(en)
|
2017-07-27 |
2019-01-31 |
The National Institute for Biotechnology in the Negev Ltd. |
SMAC / DIABLO INHIBITORS USEFUL IN THE TREATMENT OF CANCER
|
|
US11065231B2
(en)
|
2017-11-17 |
2021-07-20 |
Arvinas Operations, Inc. |
Compounds and methods for the targeted degradation of interleukin-1 receptor- associated kinase 4 polypeptides
|
|
CN119569702A
(zh)
|
2018-04-04 |
2025-03-07 |
阿尔维纳斯运营股份有限公司 |
蛋白水解调节剂及相关使用方法
|
|
US11707452B2
(en)
|
2018-08-20 |
2023-07-25 |
Arvinas Operations, Inc. |
Modulators of alpha-synuclein proteolysis and associated methods of use
|
|
WO2021011913A1
(en)
|
2019-07-17 |
2021-01-21 |
Arvinas Operations, Inc. |
Tau-protein targeting compounds and associated methods of use
|
|
ES3061133T3
(en)
|
2019-08-26 |
2026-03-31 |
Arvinas Operations Inc |
Methods of treating breast cancer with tetrahydronaphthalene derivatives as estrogen receptor degraders
|
|
EP4204418A1
(en)
|
2020-08-28 |
2023-07-05 |
Arvinas Operations, Inc. |
Rapidly accelerating fibrosarcoma protein degrading compounds and associated methods of use
|
|
AU2021342287A1
(en)
|
2020-09-14 |
2023-04-13 |
Arvinas Operations, Inc. |
Crystalline forms of a compound for the targeted degradation of estrogen receptor
|
|
EP4584258A1
(en)
|
2022-09-07 |
2025-07-16 |
Arvinas Operations, Inc. |
Rapidly accelerated fibrosarcoma (raf) degrading compounds and associated methods of use
|
|
CN121419983A
(zh)
|
2023-01-26 |
2026-01-27 |
阿尔维纳斯运营股份有限公司 |
基于小脑蛋白的kras降解protac及其相关用途
|
|
CN120555554A
(zh)
*
|
2024-06-11 |
2025-08-29 |
温州玮祎康泽生物科技有限公司 |
一种治疗肿瘤的药物
|